Ken Griffin EYEPOINT PHARMACEUTICALS INC Transaction History

Citadel Advisors LLC

  • $559 Billion
  • Q4 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
N/A
-175,282 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
N/A
175,282 New
175,282 $91,000
Q2 2020

Aug 14, 2020
SELL
N/A
-136,601 Closed
0 $0
Q1 2020

May 15, 2020
BUY
N/A
105,347 Added 337.07%
136,601 $139,000
Q4 2019

Feb 14, 2020
BUY
N/A
16,807 Added 116.34%
31,254 $48,000
Q3 2019

Nov 14, 2019
BUY
N/A
1,192 Added 8.99%
14,447 $0
Q2 2019

Aug 14, 2019
SELL
N/A
-6,680 Reduced 33.51%
13,255 $21,000
Q1 2019

May 15, 2019
SELL
N/A
-50,620 Reduced 71.75%
19,935 $0
Q4 2018

Feb 14, 2019
BUY
N/A
52,471 Added 290.15%
70,555 $0
Q3 2018

Nov 13, 2018
BUY
N/A
18,084 New
18,084 $0
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email